Research programme: cell membrane modulators - BioLine Rx
Alternative Names: BL N020; BL-2060Latest Information Update: 13 Mar 2009
At a glance
- Originator BioLineRx
- Class
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 28 Oct 2008 Preclinical trials in Bacterial infections in Israel (Inhalation)
- 28 Oct 2008 Preclinical pharmacodynamics data presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America (ICAAC/IDSA-2008)
- 16 Nov 2006 Preclinical trials in Bacterial infections in Israel (IV)